Your browser doesn't support javascript.
loading
Evaluation of the boson chemiluminescence immunoassay as a first-line screening test in the ECDC algorithm for syphilis serodiagnosis in a population with a high prevalence of syphilis.
Qiu, Xin-Hui; Zhang, Ya-Feng; Chen, Yu-Yan; Zhang, Qiao; Chen, Fu-Yi; Liu, Long; Fan, Jin-Yi; Gao, Kun; Zhu, Xiao-Zhen; Zheng, Wei-Hong; Zhang, Hui-Lin; Lin, Li-Rong; Liu, Li-Li; Tong, Man-Li; Zhang, Chang-Gong; Niu, Jian-Jun; Yang, Tian-Ci.
Afiliación
  • Qiu XH; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Zhang YF; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Chen YY; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Zhang Q; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Chen FY; Department of Physiology and Neurobiology, University of Connecticut, Storrs, Connecticut, USA.
  • Liu L; Department of Chemistry and Biology, College of Science, National University of Defense and Technology, Changsha, China.
  • Fan JY; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Gao K; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Zhu XZ; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Zheng WH; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Zhang HL; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Lin LR; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Liu LL; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Tong ML; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China.
  • Zhang CG; Boson Biotechnology Co., Ltd., Xiamen, Xiamen, China.
  • Niu JJ; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China niujianjun211@xmu.edu.cn yangtianci@xmu.edu.cn.
  • Yang TC; Zhongshan Hospital, Medical College of Xiamen University, Xiamen, China ShenZhen Research Institute of Xiamen University, ShenZhen, China niujianjun211@xmu.edu.cn yangtianci@xmu.edu.cn.
J Clin Microbiol ; 53(4): 1371-4, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25631792
ABSTRACT
We developed a new Boson chemiluminescence immunoassay (CIA) and evaluated its application with cross-sectional analyses. Our results indicated that the Boson CIA demonstrated strong discriminatory power in diagnosing syphilis and that it can be used as a first-line screening test for syphilis serodiagnosis using the European Centre for Disease Prevention and Control algorithm or as a confirmatory test when combined with a patient's clinical history.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Algoritmos / Sífilis / Mediciones Luminiscentes Tipo de estudio: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Clin Microbiol Año: 2015 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Algoritmos / Sífilis / Mediciones Luminiscentes Tipo de estudio: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Clin Microbiol Año: 2015 Tipo del documento: Article País de afiliación: China